All News

Inconsistency of insurance policy coverage, unaffordability, and difficulty accessing vaccine providers were found to be key barriers for adult immunization in a recent study by UCLA Center for Health Policy researchers.

The US Preventive Services Task Force recommends against routine screening for prostate cancer in men 70 years of age and older.

The FDA awarded the grants through the Orphan Products Clinical Trials Grants Program.

Financial modeling tool shows research and development lacking of new vaccine candidates for HIV, tuberculosis, and malaria.

By mapping out the epigenomic landscape of rheumatoid arthritis, scientists hope to gain insight on disease origins as well as new cell signaling pathways.

The CLL/SLL indication is a standard approval and the follicular lymphoma indication is an accelerated approval contingent on the results of a confirmatory trial

Officials with the FDA have approved duvelisib (Copiktra) for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) or relapsed/refractory follicular lymphoma.

World Pharmacists Day is being celebrated Tuesday around the globe.

A pharmacy owner facing an indictment charging her with submitting millions of dollars in fraudulent claims to Medicare and Medicaid is expected to be arraigned today in federal court in Brooklyn, New York.

Can you solve the pharmaceutical mystery? Each week, a new case study is presented.

A mobile app technology used to identify and track symptom relief helped measure real-time cannabis use.

Diets high in foods such as vegetables, fruit, and healthy fats found to lower the risk of death from all causes, cardiovascular disease, and cancer.

The American Hospital Association (AHA) and individual hospitals have initiated new principles for ensuring good stewardship of the 340B drug program.

A federal appropriations bill will not include bipartisan provision that would have required drug manufacturers to be more transparent with costs to consumers after it was blocked by House Republicans.

What's the best advice for a patient who is interested in a vaccine against shingles?

A coalition of health care industry leaders hosted a meeting Thursday in Washington, DC, to examine how to address this problem.

Mylan’s new Dalfampridine Extended-Release Tablets, 10 mg, an authorized generic version of Acorda's Ampyra® is being marketed to treat adult patients with multiple sclerosis.

A new report has found mortality rates for 5 of the 12 leading causes of death in the United States have increased since 2000.

A national survey demonstrated gaps in medical providers’ knowledge about changes to HIV health care delivery due to the Affordable Care Act.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

The FDA did not identify any new or unexpected safety findings with pimavanserin (Nuplazid), nor findings that are inconsistent with the established safety profile currently described in the drug label, in an analysis of all available data.

Top news of the week from Specialty Pharmacy Times.

Health, United States, 2017 includes an in-depth special feature that discusses mortality in America.

The FDA did not identify any new or unexpected safety findings with pimavanserin (Nuplazid), nor findings that are inconsistent with the established safety profile currently described in the drug label.

The social media post noted that grief counselors will be made available to associates and "will remain available as long as they are needed."

The FDA did not identify any new or unexpected safety findings with pimavanserin (Nuplazid), nor findings that are inconsistent with the established safety profile currently described in the drug label, in an analysis of all available data.

In this clip, Troy Trygstad, Editor in Chief of Pharmacy Times, interviews Jack Vallandinham, the owner of Jack’s Corner Drug Store in Sigourney, Iowa. Jack explains how he works with other health care providers and gets to know patient needs in order to provide them with optimal care.

In 2016, 5 million deaths in low- and middle-income countries (LMICs) were estimated to be due to poor-quality health care.